Dermapharm Holding SE Overview
Pro stress-test →Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals and healthcare products, founded in 1991 and based in Grünwald near Munich. The company manufactures and sells off-patent branded pharmaceutical products across Germany, France, Spain, Austria, Switzerland and internationally, operating through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business, offering branded generics, OTC products, and herbal extracts.
Strategic Profile
Pro stress-test →The company's integrated business model comprises in-house development, production and distribution of brand products by a trained pharmaceutical sales force. Dermapharm's distinctive approach combines robust in-house research and development with targeted acquisitions, such as their acquisition of the Dr. Loges-Schuten pharmaceutical company, broadening their reach into phyto-pharmaceuticals and other sectors.
Competitive Landscape
Pro stress-test →Dermapharm operates in the competitive European branded generics and OTC pharmaceutical market. Main competitors include larger pharmaceutical companies with generic divisions and specialized regional players. The company is active primarily in Germany, Switzerland and Austria, positioning it as a regional specialist in Central Europe with growing international exposure.
Industry Context
Dermapharm Holding SE operates in Specialty & Generic Drug Manufacturers.
Key facts
Founded: 1991 · Headquarters: Grünwald, Germany · Employees: 3,610 · Market cap: €2.04B